| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.11. | Alignment Healthcare stock rating upgraded by JPMorgan to Overweight | 3 | Investing.com | ||
| 03.11. | Alignment Healthcare: Goldman Sachs erhöht Kursziel auf 22 US-Dollar | 2 | Investing.com Deutsch | ||
| ALIGNMENT HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 03.11. | Alignment Healthcare stock price target raised to $22 from $21 at Goldman Sachs | 1 | Investing.com | ||
| 31.10. | Alignment Healthcare outlines 20% membership growth target for 2026 while raising full-year adjusted EBITDA outlook | 1 | Seeking Alpha | ||
| 30.10. | Alignment Healthcare übertrifft Gewinnprognose für Q3 2025, Aktie gibt dennoch nach | 2 | Investing.com Deutsch | ||
| 30.10. | Alignment Healthcare GAAP EPS of $0.02 beats by $0.09, revenue of $993.7M beats by $12.35M | 1 | Seeking Alpha | ||
| 30.10. | Alignment Healthcare Reports Second Profitable Quarter By Taming Costs | 1 | Forbes | ||
| 30.10. | Alignment Healthcare, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 30.10. | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | 906 | GlobeNewswire (Europe) | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| 30.10. | Alignment Healthcare, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 21.10. | Alignment Healthcare USA, LLC: Alignment Health Plan Joins Forces with Suvida Healthcare to Expand Bilingual Care, Access for Arizona Seniors | 1 | GlobeNewswire (USA) | ||
| 14.10. | Alignment Healthcare USA, LLC: Alignment Health Plan and Intermountain Health Launch $0-Premium, 5-star Medicare Advantage Plan for Nevada Seniors | 1 | GlobeNewswire (USA) | ||
| 10.10. | Alignment Healthcare Maintains High 2026 Star Ratings from Medicare, 100% of Members Enrolled in Plans Rated 4 Stars or Higher for Second Consecutive Year | 3 | GlobeNewswire (USA) | ||
| 01.10. | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | 320 | GlobeNewswire (Europe) | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
| 24.09. | Alignment Healthcare USA, LLC: Aging in Place, Limited Access to Medical Care and Economic Insecurity Threaten U.S. Senior Health | 1 | GlobeNewswire (USA) | ||
| 09.09. | Alignment Healthcare, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.09. | Alignment Healthcare names Matt Eyles as EVP of government strategy | 1 | Investing.com | ||
| 04.09. | Alignment Healthcare USA, LLC: Alignment Health Earns Spot on Newsweek's World's Most Trustworthy Companies 2025 List for Third Consecutive Year | 2 | GlobeNewswire (USA) | ||
| 02.09. | Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers | 2 | Benzinga.com | ||
| 28.08. | Alignment Healthcare USA, LLC: Alignment Health CEO Named "Founder of the Year" at 2025 LA Times Studios' OC Executive Forum & Leadership Awards | 2 | GlobeNewswire (USA) |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 35,790 | 0,00 % | IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range | ||
| PROCEPT BIOROBOTICS | 35,860 | 0,00 % | Procept BioRobotics stock downgraded by BofA on slowing growth | ||
| SIEMENS HEALTHINEERS | 43,650 | +2,25 % | EQS-PVR: Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Siemens Healthineers AG
Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
01.12.2025 /... ► Artikel lesen | |
| PROGYNY | 24,020 | -0,54 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 158,96 | 0,00 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| BETA BIONICS | 29,380 | 0,00 % | Beta Bionics, Inc.: Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 | ||
| FRESENIUS MEDICAL CARE | 40,220 | +0,52 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 48,240 | +0,48 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| NUTEX HEALTH | 160,95 | 0,00 % | Nutex Health extends share repurchase plan | ||
| AVEANNA HEALTHCARE | 9,310 | 0,00 % | William Blair initiates Aveanna Healthcare stock with Outperform rating | ||
| CERIBELL | 19,720 | 0,00 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| GOODRX | 2,710 | 0,00 % | HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? | ||
| CLEARPOINT NEURO | 13,540 | 0,00 % | Here's What Boosted ClearPoint Neuro (CLPT) in Q3 | ||
| ADAPTHEALTH | 9,420 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| GERRESHEIMER | 25,180 | -4,11 % | INDEX-MONITOR: JPMorgan erwartet Aumovio im MDax - Dax wohl unverändert | FRANKFURT (dpa-AFX) - Im Dax dürfte zur Index-Überprüfung an diesem Mittwoch alles beim Alten bleiben. Eine Änderung erwartet die US-Bank JPMorgan dagegen im Index der mittelgroßen Unternehmen, die... ► Artikel lesen |